歐洲末梢血管支架市場

歐洲末梢血管支架市場 是由出版商Medtech Insight在2011年10月所出版的。 這份英文市場調查報告書包含151 Pages 價格從美金4850起跳。

簡介

2010年歐洲末梢血管支架市場創下4億3,700萬美金之銷售。本市場預計今後將以9%之成長率持續增加，於2014年達到6億1,900萬美金規模。

本報告為，匯整歐洲末梢血管支架市場之產品概要、技術趨勢、目前及未來市場趨勢、競合企業及市場機會等，以下列摘要形式闡述。

實施概要

第1章 目前及新興末梢血管及非血管支架技術

• 支架設計
  支架
  • 血管
  • 非血管支架
  • 支架採用機制
• 支架材料
  • 金屬支架
  • 標準聚合物支架
  • 生物可分解聚合物支架
• 支架塗層
  • 輻射不能透過性
  • 生物相容性
  • 主動治療
• 支架之覆蓋及內裡

第2章 末梢血管支架之應用趨勢

• 心血管疾病
  • 發病及罹患率
• 末梢血管疾病
  • 末梢動脈疾病
    • 末梢動脈疾病
    • 下肢動脈疾病
    • 腎動脈狹窄
    • 動脈瘤
  • 末梢靜脈疾病
    • 慢性靜脈功能不全
    • 靜脈血栓形成
  • 原因
    • 動脈硬化
    • 高血壓
    • 糖尿病
  • 外科干預

第3章 歐洲末梢血管支架市場

• 髂動脈支架
• 股膕動脈支架
• 經頸靜脈肝內門體分流術
• 腎動脈支架
• 腹主動脈瘤覆膜支架
• 頸動脈支架
• 整合市場分析
  • 產品及技術
  • 市場分析
  • 競合分析

第4章 企業簡介

• Abbott Laboratories
• C.R. Bard, Inc.
• Boston Scientific Corporation
• Cook Group, Inc.
• ev3, Inc./Covidien, Inc.
• W.L. Gore & Associates, Inc.
• Johnson & Johnson
• Medtronic, Inc.

目錄

Abstract

First introduced in the early 1990s as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications within noncoronary vasculature. In 2010, peripheral vascular stents were used in more than 148,300 interventional procedures (including iliac artery stenting, fem-pop stenting, TIPS procedures, renal artery stenting, endovascular AAA repair, and carotid artery stenting) in the European countries covered by this report (France, Germany, Italy, Spain, and the United Kingdom) generating an estimated $437 million in corresponding product sales. Over the forecast period covered by this report, the number of peripheral vascular stenting procedures performed in Europe is expected to increase at 5% growth rate, reaching nearly 181,200 in the year 2014; during the same period, corresponding dollar sales are expected to increase at a 9% growth rate, reaching approximately $619 million in the year 2014.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European peripheral vascular stents market. Major topics covered by this report include a discussion of current and emerging peripheral vascular stenting technologies; a clinical overview of peripheral vascular conditions targeted by stenting, and an analysis of the European markets for iliac artery stents, fem-pop stents, TIPS devices, renal artery stents, AAA repair stent-grafts, and carotid artery stents.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

Table of Contents

EXECUTIVE SUMMARY

• i. Stent Design
• ii. Procedure Volumes
• iii. Market Analysis
  • a. Iliac Artery Stents
  • b. Femoropopliteal Stents
  • c. Transjugular Intrahepatic Portosystemic Shunts
  • d. Renal Artery Stents
  • e. Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts
  • f. Carotid Artery Stents

• Exhibit ES-1: Europe, Peripheral Vascular Stenting, Combined Procedure Volumes Forecast, 2010-2014
• Exhibit ES-2: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

• 1.1 Stent Design
  • 1.1.1 Vascular Stents
  • 1.1.2 Nonvascular Stents
  • 1.1.3 Stent Deployment Mechanisms
• 1.2 Stent Materials
  • 1.2.1 Metal Stents
    • 1.2.1.1 Absorbable Magnesium Alloys
    • 1.2.1.2 Cobalt Alloys
    • 1.2.1.3 Nickel-Titanium Alloys
    • 1.2.1.4 Stainless Steel
  • 1.2.2 Standard Polymeric Stents
  • 1.2.3 Biodegradable Polymeric Stents
• 1.3 Stent Coatings
  • 1.3.1 Radiopacity Enhancement
  • 1.3.2 Biocompatibility Enhancement
  • 1.3.3 Active Therapeutic Enhancement
    • 1.3.3.1 Drug-Eluting Stents
      • 1.3.3.1.1 Antirestenotic Drug-Eluting Stents
      • 1.3.3.1.2 Drug Delivery Techniques
  • 1.3.4 Stent Coverings and Linings

• Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements
• Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs
• Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials
• Exhibit 1-4: Selected Polymeric Stent Materials
• Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents
• Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents

2. OVERVIEW OF STENTING FOR PERIPHERAL VASCULAR APPLICATIONS

• 2.1 Cardiovascular Disease
  • 2.1.1 Incidence and Prevalence
• 2.2 Peripheral Vascular Disease
  • 2.2.1 Peripheral Artery Disease
    • 2.2.1.1 Carotid Artery Disease
    • 2.2.1.2 Lower Extremity Peripheral Artery Disease
    • 2.2.1.3 Mesenteric Artery Disease
  • 2.2.1.4Renal Artery Stenosis
    • 2.2.1.5 Aneurysm
      • 2.2.1.5.1 Abdominal Aortic Aneurysm
    • 2.2.1.6 Other Types of Peripheral Artery Disease
  • 2.2.2 Peripheral Venous Disorders
    • 2.2.2.1 Chronic Venous Insufficiency
    • 2.2.2.2 Thrombophlebitis
    • 2.2.2.3 Varicose Veins
  • 2.2.3 Causes
    • 2.2.3.1 Atherosclerosis
      • 2.2.3.1.1 Incidence and Prevalence
      • 2.2.3.1.2 Treatment
    • 2.2.3.2 Hypertension
      • 2.2.3.2.1 Incidence and Prevalence
      • 2.2.3.2.2 Treatment
    • 2.2.3.3 Diabetes
      • 2.2.3.3.1 Type 1 Diabetes
      • 2.2.3.3.2 Type 2 Diabetes
      • 2.2.3.3.3 Macrovascular Disease
      • 2.2.3.3.4 Hyperglycemia and Atherosclerosis
      • 2.2.3.3.5 Hyperinsulinemia and Atherosclerosis
      • 2.2.3.3.6 Incidence and Prevalence
      • 2.2.3.3.7 Treatment
  • 2.2.4 Surgical Intervention
    • 2.2.4.1 Ablative Laser-Assisted Angioplasty
    • 2.2.4.2 Bypass Grafting
    • 2.2.4.3 Catheter-Based Thrombolysis and Mechanical Thrombectomy
    • 2.2.4.4 Cryo-Balloon Angioplasty
    • 2.2.4.5 Endarterectomy
    • 2.2.4.6 Percutaneous Transluminal Angioplasty
    • 2.2.4.7 Peripheral Atherectomy
    • 2.2.4.8 Vascular Brachytherapy
    • 2.2.4.9 Intravascular Stenting
      • 2.2.4.9.1 Drug-Eluting Stents

• Exhibit 2-1: 2008, Europe, Cardiovascular Disease-Related Deaths, by Country
• Exhibit 2-2: The Peripheral Arteries
• Exhibit 2-3: Arteries of the Head and Neck
• Exhibit 2-4: Arteries of the Lower Body
• Exhibit 2-5: Classification of Abdominal Aortic Aneurysms
• Exhibit 2-6: 2008, Europe, Deaths Due to Ischemic Heart Disease, by Age
• Exhibit 2-7: 2004, Systolic Blood Pressure Levels in Selected European Countries
• Exhibit 2-8: 2010, Europe, Diabetes Prevalence, by Country

3. EUROPEAN PERIPHERAL VASCULAR STENTS MARKET

• 3.1 Iliac Artery Stents
  • 3.1.1 Products and Technologies
  • 3.1.2 Market Analysis
  • 3.1.3 Competitive Analysis
• 3.2 Femoropopliteal Stents
  • 3.2.1 Products and Technologies
  • 3.2.2 Market Analysis
  • 3.2.3 Competitive Analysis
• 3.3 Transjugular Intrahepatic Portosystemic Shunts
  • 3.3.1 Products and Technologies
  • 3.3.2 Market Analysis
  • 3.3.3 Competitive Analysis
• 3.4 Renal Artery Stents
  • 3.4.1 Products and Technologies
  • 3.4.2 Market Analysis
  • 3.4.3 Competitive Analysis
• 3.5 Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts
  • 3.5.1 Products and Technologies
  • 3.5.2 Market Analysis
  • 3.5.3 Competitive Analysis
• 3.6 Carotid Artery Stents
  • 3.6.1 Products and Technologies
  • 3.6.2 Market Analysis
  • 3.6.3 Competitive Analysis
• 3.7 Combined Market Analysis
  • 3.7.1 Market Drivers
  • 3.7.2 Market Limiters
  • 3.7.3 Market Forecast

• Exhibit 3-1: 2011, Selected Iliac Artery Stents
• Exhibit 3-2: Europe, Iliac Artery Stenting, Procedure Volumes Forecast, 2010-2014
• Exhibit 3-3: Europe, Iliac Artery Stents, Market Forecast, 2010-2014
• Exhibit 3-4: 2010, Europe, Iliac Artery Stents Market, Share by Supplier
• Exhibit 3-5: 2011, Selected Femoropopliteal Stents
• Exhibit 3-6: Europe, Femoropopliteal Stenting, Procedure Volumes Forecast, 2010-2014
• Exhibit 3-7: Europe, Femoropopliteal Stents, Market Forecast, 2010-2014
• Exhibit 3-8: 2010, Europe, Femoropopliteal Stents Market, Share by Supplier
• Exhibit 3-9: 2011, Selected Transjugular Intrahepatic Portosystemic Shunts
• Exhibit 3-10: Europe, Transjugular Intrahepatic Portosystemic Shunting, Procedure Volumes Forecast, 2010-2014
• Exhibit 3-11: Europe, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2010-2014
• Exhibit 3-12: 2010, Europe, Transjugular Intrahepatic Portosystemic Shunts Market, Share by Supplier
• Exhibit 3-13: 2011, Selected Renal Artery Stents
• Exhibit 3-14: Europe, Renal Artery Stenting, Procedure Volumes Forecast, 2010-2014
• Exhibit 3-15: Europe, Renal Artery Stents, Market Forecast, 2010-2014
• Exhibit 3-16: 2010, Europe, Renal Artery Stents Market, Share by Supplier
• Exhibit 3-17: 2011, Selected Endovascular Abdominal Aortic Aneurysm Stent-Grafts
• Exhibit 3-18: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Graft Repair, Procedure Volumes Forecast, 2010-2014
• Exhibit 3-19: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2010-2014
• Exhibit 3-20: 2010, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier
• Exhibit 3-21: 2011, Selected Carotid Artery Stents
• Exhibit 3-22: Europe, Carotid Artery Stenting, Procedure Volumes Forecast, 2010-2014
• Exhibit 3-23: Europe, Carotid Artery Stents, Market Forecast, 2010-2014
• Exhibit 3-24: 2010, Europe, Carotid Artery Stents Market, Share by Supplier
• Exhibit 3-25: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014

4. COMPANY PROFILES

• 4.1 Abbott Laboratories
• 4.2 C.R. Bard, Inc.
• 4.3 Boston Scientific Corporation
• 4.4 Cook Group, Inc.
• 4.5 ev3, Inc./Covidien, Inc.
• 4.6 W.L. Gore & Associates, Inc.
• 4.7 Johnson & Johnson
• 4.8 Medtronic, Inc.

相關商品

導管相關市場調查報告書

亞太地區的經導管栓塞·阻塞設備市場:2012年
Asia Pacific Markets for Transcatheter Embolization and Occlusion Devices 2012
價格 : US $ 6995
出版日期 : 2012年04月

歐洲的藥劑溶出性血管支架市場:2011年∼2015年
Drug-eluting Stent Market in Europe 2011-2015
價格 : US $ 1500
出版日期 : 2012年04月

全球支架血管市場：2011年∼2015年
Global Stent Grafts Market 2011-2015
價格 : US $ 1500
出版日期 : 2012年04月

Medtech Insight發行的醫療設備相關市場調查報告書

心臟疾病治療的既有技術與新興技術：美國市場

United States Markets for Current and Emerging Technologies for the Treatment of Heart Failure

價格 : US $ 4750

出版日期 : 2012年03月

美國外科手術量

U.S. Surgical Procedure Volumes

價格 : US $ 4750

出版日期 : 2012年02月

歐洲的心臟瓣膜修復・置換產品市場

European Markets for Heart Valve Repair and Replacement Products

價格 : US $ 4850

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!